539561 Stock Overview A pharmaceutical company, engages in the trading and sale of active pharmaceutical ingredients (API) and intermediates in India and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Remedium Lifecare Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Remedium Lifecare Historical stock prices Current Share Price ₹5.21 52 Week High ₹38.25 52 Week Low ₹5.01 Beta 1.17 1 Month Change -14.17% 3 Month Change -42.56% 1 Year Change -79.15% 3 Year Change 323.30% 5 Year Change 2,481.96% Change since IPO 4,531.15%
Recent News & Updates
Second quarter 2025 earnings released: EPS: ₹0.04 (vs ₹0.16 in 2Q 2024) Nov 16
Remedium Lifecare Limited to Report Q2, 2025 Results on Nov 14, 2024 Nov 09
High number of new and inexperienced directors Nov 08
Investor sentiment improves as stock rises 16% Nov 05
Investor sentiment deteriorates as stock falls 15% Oct 16
Remedium Lifecare to Consider Acquisition of Airowater Global Trading Aug 29 See more updates
Second quarter 2025 earnings released: EPS: ₹0.04 (vs ₹0.16 in 2Q 2024) Nov 16
Remedium Lifecare Limited to Report Q2, 2025 Results on Nov 14, 2024 Nov 09
High number of new and inexperienced directors Nov 08
Investor sentiment improves as stock rises 16% Nov 05
Investor sentiment deteriorates as stock falls 15% Oct 16
Remedium Lifecare to Consider Acquisition of Airowater Global Trading Aug 29
Remedium Lifecare to Consider Acquisition of Airowater Global Trading Aug 28
First quarter 2025 earnings released: EPS: ₹0.16 (vs ₹0.15 in 1Q 2024) Aug 15
Remedium Lifecare Limited Appoints Neeraj Ramashankar Yadav as Whole Time Company Secretary and Compliance Officer Aug 14
Investor sentiment deteriorates as stock falls 22% Aug 14
Investor sentiment deteriorates as stock falls 22% Jul 25
Remedium Lifecare Limited to Report Q1, 2025 Results on Aug 08, 2024 Jul 16
Investor sentiment improves as stock rises 21% Jul 02
Remedium Lifecare Limited Announces the Resignation of Dhwani Desai as Company Secretary and Compliance Officer Jun 15
Remedium Lifecare Limited, Annual General Meeting, Jun 26, 2024 Jun 05
Full year 2024 earnings released: EPS: ₹90.92 (vs ₹0.54 in FY 2023) May 28
Investor sentiment deteriorates as stock falls 16% May 10
Remedium Lifecare Limited to Report Q4, 2024 Results on May 10, 2024 May 05
Less than half of directors are independent Apr 20
Investor sentiment deteriorates as stock falls 21% Mar 14
Investor sentiment improves as stock rises 43% Feb 21
Third quarter 2024 earnings released: EPS: ₹34.12 (vs ₹0.76 in 3Q 2023) Feb 15
Remedium Lifecare Limited to Report Nine Months, 2024 Results on Feb 14, 2024 Feb 07
New minor risk - Share price stability Dec 05
Remedium Lifecare Limited Appoints Dhwani Desai as Whole Time Company Secretary and Compliance Officer Nov 22
New minor risk - Profit margin trend Nov 19
Remedium Lifecare Limited Announces Resignation of Ashvini Dhuri as Company Secretary / Compliance Officer Sep 09
Remedium Lifecare Limited Announces the Resignation of Dr. Vilas Ramkrishna Lokhande from the Position of Whole Time Director Aug 27
Remedium Lifecare Limited to Report Q1, 2024 Results on Aug 12, 2023 Aug 04
New minor risk - Market cap size Jul 27
Remedium Lifecare Limited, Annual General Meeting, Jul 20, 2023 Jun 24
New minor risk - Share price stability Jun 15
Full year 2023 earnings released: EPS: ₹15.07 (vs ₹2.99 in FY 2022) Jun 02
Remedium Lifecare Limited to Report Q4, 2023 Results on May 30, 2023 May 25
Investor sentiment improves as stock rises 22% Apr 17
Investor sentiment improves as stock rises 27% Mar 02
Investor sentiment deteriorates as stock falls 15% Feb 16
Third quarter 2023 earnings released Feb 09
Remedium Lifecare Limited to Report Q3, 2023 Results on Feb 07, 2023 Jan 31
Investor sentiment improved over the past week Jan 19
Remedium Lifecare Limited (BSE : 539561) entered into an Memorandum of Understanding to acquire Mvk Lifesciences Private Limited. Nov 16
Second quarter 2023 earnings released: EPS: ₹6.08 (vs ₹3.06 in 2Q 2022) Nov 06
Remedium Lifecare Limited to Report Q2, 2023 Results on Nov 04, 2022 Oct 19
Remedium Lifecare Limited, Annual General Meeting, Sep 20, 2022 Aug 27
First quarter 2023 earnings released Aug 18
Full year 2022 earnings released Jun 04
Remedium Lifecare Limited to Report Q4, 2022 Results on May 30, 2022 May 25
Less than half of directors are independent Apr 27
Third quarter 2022 earnings: Revenues in line with analyst expectations Feb 11
Remedium Lifecare Limited to Report Q3, 2022 Results on Feb 09, 2022 Feb 03
High number of new and inexperienced directors Sep 15
High number of new and inexperienced directors Sep 13
High number of new and inexperienced directors Sep 11
High number of new and inexperienced directors Sep 09
Woman Independent Director recently bought ₹487k worth of stock Jul 20
Company Secretary & Compliance Officer Nishant Phadtare has left the company Jul 15
First quarter 2022 earnings released Jul 08
Investor sentiment improved over the past week May 05
Remedium Lifecare Limited to Report Q3, 2020 Results on Feb 12, 2021 Feb 04
Investor sentiment deteriorated over the past week Feb 01
Investor sentiment improved over the past week Jan 15
New 90-day high: ₹50.00 Jan 07
Investor sentiment improved over the past week Dec 31
New 90-day high: ₹32.80 Dec 16
Investor sentiment improved over the past week Dec 16
New 90-day low: ₹29.45 Nov 19
Remedium Lifecare Limited to Report Q2, 2021 Results on Nov 13, 2020 Nov 08
Roxy Exports Limited Approves Appointment of Ms. Trupti Bolke as an Independent Director Oct 01
Full year earnings released - EPS ₹0.77 Sep 11 Shareholder Returns 539561 IN Pharmaceuticals IN Market 7D -1.1% 0.8% -4.2% 1Y -79.2% 39.7% 19.1%
See full shareholder returns
Return vs Market: 539561 underperformed the Indian Market which returned 19.1% over the past year.
Price Volatility Is 539561's price volatile compared to industry and market? 539561 volatility 539561 Average Weekly Movement 5.7% Pharmaceuticals Industry Average Movement 6.0% Market Average Movement 6.2% 10% most volatile stocks in IN Market 9.0% 10% least volatile stocks in IN Market 4.1%
Stable Share Price: 539561 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 539561's weekly volatility (6%) has been stable over the past year.
About the Company Remedium Lifecare Limited, a pharmaceutical company, engages in the trading and sale of active pharmaceutical ingredients (API) and intermediates in India and internationally. The company offers API intermediates and other products for the use in iso propyl alcohol, cyclohexane di iso propyl amine, ethyl acetate, hydrazine hydrate, iso propyl alcohol, methylene di chloride, potassium carbonate powder, sodium bi-carbonate, potassium hydroxide flakes, sodium chloride and carbonate, amino isophthalic acid, tellurium(iv) oxide, grignard reagent, iodine, selenium metal powder, and trimethyl sulfoxonium iodide. The company was formerly known as Roxy Exports Limited and changed its name to Remedium Lifecare Limited in November 2020.
Show more Remedium Lifecare Limited Fundamentals Summary How do Remedium Lifecare's earnings and revenue compare to its market cap? 539561 fundamental statistics Market cap ₹2.10b Earnings (TTM ) ₹241.05m Revenue (TTM ) ₹33.45b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 539561 income statement (TTM ) Revenue ₹33.45b Cost of Revenue ₹33.15b Gross Profit ₹307.55m Other Expenses ₹66.50m Earnings ₹241.05m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) 0.60 Gross Margin 0.92% Net Profit Margin 0.72% Debt/Equity Ratio 395.4%
How did 539561 perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/21 21:16 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Remedium Lifecare Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
